lanreotide
(PUDHBTGHUJUUFI-UHFFFAOYSA-N)
Structure
- SMILES
- NCCCCC1NC(=O)C(NC(=O)C(Cc2ccc(cc2)O)NC(=O)C(CSSCC(NC(=O)C(NC1=O)C(C)C)C(=O)NC(C(=O)N)C(O)C)NC(=O)C(Cc1ccc2c(c1)cccc2)N)Cc1c[nH]c2c1cccc2
- Type(s)
- Approved
- ATC code(s)
- H01CB03
- Molecular Formula:
- C54H69N11O10S2
- Molecular Weight:
- 1096.320
- Log P:
- 5.3483
- Hydrogen Bond Acceptor:
- 22
- Hydrogen Bond Donor:
- 13
- TPSA:
- 405.68
- CAS Number(s):
- 108736-35-2; 127984-74-1
Synonym(s)
1.
lanreotide
2.
188Re-lanreotide
3.
2-naphthylalanyl-cyclo(cysteinyl-tyrosyl-tryptophyl-lysyl-valyl-cysteinyl)-threoninamide
4.
BIM 23014
5.
BIM 23014C
6.
BIM-23014
7.
DC 13-116
8.
DC-13-116
9.
DC13-116
10.
L-Threoninamide, 3-(2-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2-7)-disulfide
11.
Nal-cyclo(Cys-Tyr-Trp-Lys-Val-Cys)-Thr-NH2
12.
Nal-cyclo(Cys-Tyr-Trp-Lys-Val-Cys)Thr-NH2
13.
Somatulin
14.
Somatulina
15.
Somatuline
16.
lanreotide acetate
17.
lanreotide-SR
18.
naphthalenyl-cyclo(cysteinyl-tyrosyl-tryptophyl-lysyl-valyl-cysteinyl)threoninamide
19.
naphthyl-cyclo(Cys-Tyr-Trp-Lys-Val-Cys)Thr-NH2
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Abdominal Pain | FAERS: 15 Canada Vigilance: 17 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 2 | Nausea | FAERS: 14 Canada Vigilance: 13 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 3 | Inappropriate schedule of drug administration | FAERS: 13 | US FAERS | |
| 4 | Malaise | FAERS: 13 Canada Vigilance: 10 | Canada Vigilance SIDER US FAERS | |
| 5 | Asthenia | FAERS: 12 Canada Vigilance: 8 | Canada Vigilance SIDER US FAERS | |
| 6 | Injection site pain | FAERS: 12 Canada Vigilance: 3 | Canada Vigilance SIDER US FAERS | |
| 7 | Cholelithiasis | FAERS: 10 Canada Vigilance: 3 | Canada Vigilance SIDER US FAERS | |
| 8 | Fatigue | FAERS: 10 Canada Vigilance: 14 | Canada Vigilance SIDER US FAERS | |
| 9 | Headache | FAERS: 10 Canada Vigilance: 5 | Canada Vigilance SIDER US FAERS | |
| 10 | Pain | FAERS: 9 Canada Vigilance: 6 | Canada Vigilance SIDER US FAERS | |
| 11 | Alopecia | FAERS: 8 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 12 | Flushing | FAERS: 7 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 13 | Injection site mass | FAERS: 7 Canada Vigilance: 2 | Canada Vigilance SIDER US FAERS | |
| 14 | Injection site nodule | FAERS: 7 | OFFSIDES SIDER US FAERS | |
| 15 | Vomiting | FAERS: 7 Canada Vigilance: 12 | Canada Vigilance SIDER US FAERS | |
| 16 | Disease Progression | FAERS: 6 Canada Vigilance: 2 | Canada Vigilance OFFSIDES US FAERS | |
| 17 | Drug ineffective | FAERS: 6 Canada Vigilance: 27 | Canada Vigilance US FAERS | |
| 18 | Palpitations | FAERS: 6 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 19 | Overdose | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 20 | Diabetes Mellitus | FAERS: 4 Canada Vigilance: 2 | Canada Vigilance SIDER US FAERS | |
| 21 | Dizziness | FAERS: 4 Canada Vigilance: 6 | Canada Vigilance SIDER US FAERS | |
| 22 | General physical health deterioration | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 23 | Pruritus | FAERS: 4 | SIDER US FAERS | |
| 24 | Anxiety | FAERS: 3 | SIDER US FAERS | |
| 25 | Arthralgia | FAERS: 3 Canada Vigilance: 4 | Canada Vigilance SIDER US FAERS | |
| 26 | Biliary Colic | FAERS: 3 | US FAERS | |
| 27 | Bradycardia | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 28 | Chest Pain | FAERS: 3 Canada Vigilance: 2 | Canada Vigilance SIDER US FAERS | |
| 29 | Drug administered at inappropriate site | FAERS: 3 | US FAERS | |
| 30 | Feeling abnormal | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 31 | Flatulence | FAERS: 3 Canada Vigilance: 8 | Canada Vigilance SIDER US FAERS | |
| 32 | Incorrect route of drug administration | FAERS: 3 | US FAERS | |
| 33 | Product dose omission | FAERS: 3 Canada Vigilance: 7 | Canada Vigilance US FAERS | |
| 34 | Retching | FAERS: 3 | US FAERS | |
| 35 | Terminal state | FAERS: 3 | US FAERS | |
| 36 | Urinary tract infection | FAERS: 3 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 37 | Wrong technique in product usage process | FAERS: 3 | US FAERS | |
| 38 | Abdominal discomfort | FAERS: 2 Canada Vigilance: 4 | Canada Vigilance SIDER US FAERS | |
| 39 | Alanine Aminotransferase Increased | FAERS: 2 | SIDER US FAERS | |
| 40 | Aspartate Aminotransferase Increased | FAERS: 2 | SIDER US FAERS | |
| 41 | Biliary dilatation | FAERS: 2 | US FAERS | |
| 42 | Blood glucose abnormal | FAERS: 2 | US FAERS | |
| 43 | Blood glucose increased | FAERS: 2 Canada Vigilance: 3 | Canada Vigilance SIDER US FAERS | |
| 44 | Blood magnesium decreased | FAERS: 2 | US FAERS | |
| 45 | Cholangitis | FAERS: 2 | US FAERS | |
| 46 | Chronic gastritis | FAERS: 2 | US FAERS | |
| 47 | Device occlusion | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 48 | Discomfort | FAERS: 2 | SIDER US FAERS | |
| 49 | Dry skin | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 50 | Erythema | FAERS: 2 | US FAERS | |
| 51 | Gamma-Glutamyltransferase Increased | FAERS: 2 | US FAERS | |
| 52 | Gastrointestinal stoma complication | FAERS: 2 | US FAERS | |
| 53 | Hypersensitivity | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 54 | Inappropriate schedule of product administration | FAERS: 2 Canada Vigilance: 11 | Canada Vigilance US FAERS | |
| 55 | Injection site discomfort | FAERS: 2 | US FAERS | |
| 56 | Injection site erythema | FAERS: 2 | US FAERS | |
| 57 | Injection site pruritus | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance OFFSIDES US FAERS | |
| 58 | Injury associated with device | FAERS: 2 | US FAERS | |
| 59 | Intestinal Obstruction | FAERS: 2 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 60 | Lethargy | FAERS: 2 | US FAERS | |
| 61 | Malignant neoplasm progression | FAERS: 2 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 62 | Myalgia | FAERS: 2 Canada Vigilance: 3 | Canada Vigilance SIDER US FAERS | |
| 63 | Nasopharyngitis | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 64 | Pancreatitis | FAERS: 2 Canada Vigilance: 3 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 65 | Pneumonia | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 66 | Prescribed underdose | FAERS: 2 | US FAERS | |
| 67 | Product administered at inappropriate site | FAERS: 2 | US FAERS | |
| 68 | Product use issue | FAERS: 2 | US FAERS | |
| 69 | Septic Shock | FAERS: 2 | US FAERS | |
| 70 | Sinusitis | FAERS: 2 | US FAERS | |
| 71 | Abasia | FAERS: 1 | US FAERS | |
| 72 | Abdominal adhesions | FAERS: 1 | US FAERS | |
| 73 | Accidental exposure to product | FAERS: 1 | US FAERS | |
| 74 | Adverse event | FAERS: 1 | US FAERS | |
| 75 | Agitation | FAERS: 1 | US FAERS | |
| 76 | Anger | FAERS: 1 | US FAERS | |
| 77 | Anorectal discomfort | FAERS: 1 | US FAERS | |
| 78 | Arthropathy | FAERS: 1 | US FAERS | |
| 79 | Atrial Flutter | FAERS: 1 | US FAERS | |
| 80 | Back Pain | FAERS: 1 Canada Vigilance: 7 | Canada Vigilance SIDER US FAERS | |
| 81 | Bladder Neoplasm | FAERS: 1 | US FAERS | |
| 82 | Blood glucose decreased | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 83 | Bronchitis | FAERS: 1 | OFFSIDES SIDER US FAERS | |
| 84 | Carcinoid Heart Disease | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 85 | Cardiomegaly | FAERS: 1 | SIDER US FAERS | |
| 86 | Cerebrovascular accident | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 87 | Chemotherapy | FAERS: 1 | US FAERS | |
| 88 | Chest discomfort | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 89 | Chills | FAERS: 1 | US FAERS | |
| 90 | Constipation | FAERS: 1 Canada Vigilance: 4 | Canada Vigilance SIDER US FAERS | |
| 91 | Delayed sleep phase | FAERS: 1 | US FAERS | |
| 92 | Delirium | FAERS: 1 | US FAERS | |
| 93 | Delusional disorder, persecutory type | FAERS: 1 | US FAERS | |
| 94 | Diverticulitis | FAERS: 1 | US FAERS | |
| 95 | Drug abuse | FAERS: 1 | US FAERS | |
| 96 | Drug effect incomplete | FAERS: 1 | US FAERS | |
| 97 | Dyschezia | FAERS: 1 | US FAERS | |
| 98 | Dyspepsia | FAERS: 1 Canada Vigilance: 3 | Canada Vigilance SIDER US FAERS | |
| 99 | Glioblastoma Multiforme | FAERS: 1 | US FAERS | |
| 100 | Hepatectomy | FAERS: 1 | US FAERS | |
| 101 | Hospice Care | FAERS: 1 | US FAERS | |
| 102 | Hypopituitarism | FAERS: 1 | US FAERS | |
| 103 | Hypotension | FAERS: 1 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 104 | Impaired insulin secretion | FAERS: 1 | US FAERS | |
| 105 | Incorrect drug administration duration | FAERS: 1 | US FAERS | |
| 106 | Incorrect product storage | FAERS: 1 | US FAERS | |
| 107 | Infection | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 108 | Influenza | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 109 | Injection site bruising | FAERS: 1 | US FAERS | |
| 110 | Injection site extravasation | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 111 | Injection site hypersensitivity | FAERS: 1 | US FAERS | |
| 112 | Injection site necrosis | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 113 | Injection site scar | FAERS: 1 | US FAERS | |
| 114 | Injection site urticaria | FAERS: 1 | US FAERS | |
| 115 | Insulin-like growth factor increased | FAERS: 1 | US FAERS | |
| 116 | Irritable Bowel Syndrome | FAERS: 1 | US FAERS | |
| 117 | Joint Range of Motion Decreased | FAERS: 1 | US FAERS | |
| 118 | Joint swelling | FAERS: 1 | US FAERS | |
| 119 | Lack of injection site rotation | FAERS: 1 | US FAERS | |
| 120 | Mechanical ileus | FAERS: 1 | US FAERS | |
| 121 | Memory impairment | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 122 | Metastasis | FAERS: 1 | US FAERS | |
| 123 | Migraine with Aura | FAERS: 1 | US FAERS | |
| 124 | Nephrolithiasis | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 125 | Otitis Externa | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 126 | Pain of skin | FAERS: 1 | US FAERS | |
| 127 | Peritoneal Dialysis | FAERS: 1 | US FAERS | |
| 128 | Peritonitis | FAERS: 1 | US FAERS | |
| 129 | Product label issue | FAERS: 1 | US FAERS | |
| 130 | Product storage error | FAERS: 1 | US FAERS | |
| 131 | Pulmonary Embolism | FAERS: 1 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 132 | Pyelonephritis | FAERS: 1 | US FAERS | |
| 133 | Renal Colic | FAERS: 1 | US FAERS | |
| 134 | Sciatica | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 135 | Sinus bradycardia | FAERS: 1 | SIDER US FAERS | |
| 136 | Swelling | FAERS: 1 | US FAERS | |
| 137 | Syncope | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 138 | Tinnitus | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 139 | Tremor | FAERS: 1 | US FAERS | |
| 140 | Unevaluable event | FAERS: 1 | US FAERS | |
| 141 | Urticaria | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 142 | Uterine Polyp | FAERS: 1 | US FAERS | |
| 143 | Vertigo | FAERS: 1 | SIDER US FAERS | |
| 144 | Visual Impairment | FAERS: 1 | SIDER US FAERS | |
| 145 | Weight decreased | FAERS: 1 Canada Vigilance: 7 | Canada Vigilance SIDER US FAERS | |
| 146 | Wheelchair user | FAERS: 1 | US FAERS | |
| 147 | Wound Complication | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 148 | X-ray abnormal | FAERS: 1 | US FAERS | |
| 149 | jaundice | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 150 | nervous system disorder | FAERS: 1 | SIDER US FAERS | |
| 151 | Abscess | OFFSIDES | ||
| 152 | Acromegaly | 10601961 | CTD | |
| 153 | Acute Coronary Syndrome | SIDER | ||
| 154 | Allergic skin reaction | SIDER | ||
| 155 | Ammonia increased | Canada Vigilance: 1 | Canada Vigilance | |
| 156 | Anal abscess | Canada Vigilance: 1 | Canada Vigilance | |
| 157 | Anaphylactic shock | SIDER | ||
| 158 | Angioedema | Canada Vigilance: 3 | Canada Vigilance SIDER | |
| 159 | Anorexia | SIDER | ||
| 160 | Aortic Valve Stenosis | SIDER | ||
| 161 | Aphagia | OFFSIDES | ||
| 162 | Application site acne | Canada Vigilance: 1 | Canada Vigilance | |
| 163 | Atrial arrhythmia | SIDER | ||
| 164 | Atrioventricular Block | SIDER | ||
| 165 | Autonomic nervous system imbalance | SIDER | ||
| 166 | Blood Glucose | Canada Vigilance: 1 | Canada Vigilance | |
| 167 | Blood alkaline phosphatase increased | SIDER | ||
| 168 | Blood bilirubin abnormal | SIDER | ||
| 169 | Blood creatinine increased | Canada Vigilance: 2 | Canada Vigilance | |
| 170 | Blood magnesium abnormal | Canada Vigilance: 1 | Canada Vigilance | |
| 171 | Blood sodium abnormal | Canada Vigilance: 1 | Canada Vigilance | |
| 172 | Blood thyroid stimulating hormone decreased | Canada Vigilance: 1 | Canada Vigilance | |
| 173 | Blood urine present | Canada Vigilance: 1 | Canada Vigilance | |
| 174 | Bone pain | SIDER | ||
| 175 | Bursitis | SIDER | ||
| 176 | Carcinoid crisis | Canada Vigilance: 1 | Canada Vigilance | |
| 177 | Cataract | SIDER | ||
| 178 | Cholecystitis infective | Canada Vigilance: 2 | Canada Vigilance | |
| 179 | Cholecystitis | Canada Vigilance: 1 | Canada Vigilance SIDER | |
| 180 | Chromaturia | Canada Vigilance: 1 | Canada Vigilance | |
| 181 | Clostridium difficile infection | Canada Vigilance: 1 | Canada Vigilance | |
| 182 | Cold sweat | Canada Vigilance: 1 | Canada Vigilance | |
| 183 | Cytolytic hepatitis | OFFSIDES | ||
| 184 | Deep Vein Thrombosis | Canada Vigilance: 1 | Canada Vigilance | |
| 185 | Dehydration | Canada Vigilance: 3 | Canada Vigilance | |
| 186 | Dementia | Canada Vigilance: 1 | Canada Vigilance | |
| 187 | Depressed Level of Consciousness | Canada Vigilance: 2 | Canada Vigilance | |
| 188 | Depressed mood | Canada Vigilance: 1 | Canada Vigilance | |
| 189 | Device leakage | Canada Vigilance: 1 | Canada Vigilance | |
| 190 | Diabetes mellitus exacerbated | SIDER | ||
| 191 | Diabetes mellitus inadequate control | Canada Vigilance: 1 | Canada Vigilance | |
| 192 | Diarrhea | OFFSIDES | ||
| 193 | Drooling | Canada Vigilance: 1 | Canada Vigilance | |
| 194 | Dysautonomia | SIDER | ||
| 195 | Dysphonia | Canada Vigilance: 1 | Canada Vigilance | |
| 196 | Dysthymic Disorder | OFFSIDES | ||
| 197 | Dysuria | SIDER | ||
| 198 | Eating disorder symptom | Canada Vigilance: 1 | Canada Vigilance | |
| 199 | Electrocardiogram abnormal | SIDER | ||
| 200 | Endometrial disorder | SIDER | ||
| 201 | Erectile dysfunction | SIDER | ||
| 202 | Eructation | Canada Vigilance: 1 | Canada Vigilance | |
| 203 | Facial paralysis | Canada Vigilance: 1 | Canada Vigilance | |
| 204 | Fatty Liver | OFFSIDES | ||
| 205 | Feeling of body temperature change | Canada Vigilance: 1 | Canada Vigilance | |
| 206 | Flank Pain | Canada Vigilance: 2 | Canada Vigilance | |
| 207 | Food craving | Canada Vigilance: 1 | Canada Vigilance | |
| 208 | Gait inability | Canada Vigilance: 3 | Canada Vigilance | |
| 209 | Gallbladder Sludge | SIDER | ||
| 210 | Gastrointestinal Pain | SIDER | ||
| 211 | Gout | Canada Vigilance: 1 | Canada Vigilance | |
| 212 | Hepatic Encephalopathy | Canada Vigilance: 1 | Canada Vigilance | |
| 213 | Hepatic Infection | Canada Vigilance: 1 | Canada Vigilance | |
| 214 | Hepatic artery embolism | Canada Vigilance: 1 | Canada Vigilance | |
| 215 | Hepatic necrosis | Canada Vigilance: 1 | Canada Vigilance | |
| 216 | Hepatomegaly | SIDER | ||
| 217 | Hepatosplenomegaly | SIDER | ||
| 218 | Hyperphagia | Canada Vigilance: 1 | Canada Vigilance | |
| 219 | Hypertension worsened | SIDER | ||
| 220 | Hypothyroidism | SIDER | ||
| 221 | Hypotrichosis | SIDER | ||
| 222 | Hypoventilation | Canada Vigilance: 1 | Canada Vigilance | |
| 223 | Incorrect route of product administration | Canada Vigilance: 3 | Canada Vigilance | |
| 224 | Induration | SIDER | ||
| 225 | Inflammation | SIDER | ||
| 226 | Injection Site Reaction | SIDER | ||
| 227 | Injection site inflammation | SIDER | ||
| 228 | Injection site irritation | OFFSIDES | ||
| 229 | Injection site ulcer | Canada Vigilance: 1 | Canada Vigilance | |
| 230 | Insulin Resistance | OFFSIDES | ||
| 231 | Intention tremor | OFFSIDES | ||
| 232 | Joint injury | Canada Vigilance: 2 | Canada Vigilance | |
| 233 | Leukopenia | SIDER | ||
| 234 | Liver Abscess | Canada Vigilance: 1 | Canada Vigilance | |
| 235 | Liver Cirrhosis | 19874807 | CTD | |
| 236 | Liver Neoplasms, Experimental | 19874807 | CTD | |
| 237 | Loss of personal independence in daily activities | Canada Vigilance: 1 | Canada Vigilance | |
| 238 | Lower respiratory tract infection | Canada Vigilance: 1 | Canada Vigilance | |
| 239 | Malnutrition | SIDER | ||
| 240 | Microlithiasis | OFFSIDES | ||
| 241 | Musculoskeletal chest pain | Canada Vigilance: 2 | Canada Vigilance | |
| 242 | Musculoskeletal discomfort | SIDER | ||
| 243 | Myocardial Infarction | Canada Vigilance: 1 | Canada Vigilance SIDER | |
| 244 | Nervousness | SIDER | ||
| 245 | Nodule | Canada Vigilance: 1 | Canada Vigilance SIDER | |
| 246 | Obstruction | OFFSIDES | ||
| 247 | Oncologic complication | Canada Vigilance: 2 | Canada Vigilance | |
| 248 | Onychoclasis | OFFSIDES | ||
| 249 | Palliative Care | Canada Vigilance: 3 | Canada Vigilance | |
| 250 | Pelvic Pain | Canada Vigilance: 1 | Canada Vigilance | |
| 251 | Performance status decreased | Canada Vigilance: 1 | Canada Vigilance | |
| 252 | Peripheral swelling | Canada Vigilance: 2 | Canada Vigilance | |
| 253 | Pharyngitis | Canada Vigilance: 1 | Canada Vigilance | |
| 254 | Poor quality sleep | Canada Vigilance: 1 | Canada Vigilance | |
| 255 | Procedural complication | OFFSIDES | ||
| 256 | Productive Cough | Canada Vigilance: 1 | Canada Vigilance | |
| 257 | Pulmonary congestion | Canada Vigilance: 1 | Canada Vigilance | |
| 258 | Pulmonary thrombosis | Canada Vigilance: 1 | Canada Vigilance | |
| 259 | Purulence | OFFSIDES | ||
| 260 | Rales | Canada Vigilance: 1 | Canada Vigilance | |
| 261 | Reaction gastrointestinal | SIDER | ||
| 262 | Regurgitation | OFFSIDES SIDER | ||
| 263 | Renal pain | SIDER | ||
| 264 | Respiratory distress | Canada Vigilance: 2 | Canada Vigilance | |
| 265 | Rhinitis | SIDER | ||
| 266 | Subcutaneous Abscess | Canada Vigilance: 1 | Canada Vigilance | |
| 267 | Suprapubic pain | Canada Vigilance: 1 | Canada Vigilance | |
| 268 | Tachyarrhythmia | Canada Vigilance: 1 | Canada Vigilance | |
| 269 | Temperature intolerance | OFFSIDES | ||
| 270 | Tension | SIDER | ||
| 271 | Therapeutic product effect decreased | Canada Vigilance: 3 | Canada Vigilance | |
| 272 | Therapy cessation | Canada Vigilance: 1 | Canada Vigilance | |
| 273 | Thrombin time abnormal | OFFSIDES | ||
| 274 | Thrombocytopenia | Canada Vigilance: 1 | Canada Vigilance | |
| 275 | Thrombosis | Canada Vigilance: 1 | Canada Vigilance | |
| 276 | Tinea Pedis | Canada Vigilance: 1 | Canada Vigilance | |
| 277 | Troponin increased | Canada Vigilance: 1 | Canada Vigilance | |
| 278 | Ultrasound abdomen abnormal | Canada Vigilance: 1 | Canada Vigilance | |
| 279 | Ventricular arrhythmia | SIDER | ||
| 280 | Wound Infection | Canada Vigilance: 1 | Canada Vigilance | |
| 281 | skin abrasion | Canada Vigilance: 2 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120236
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.